The Evaluation of Liver Fibrosis Regression in Chronic Hepatitis C Patients After the Treatment with Direct-Acting Antiviral Agents—A Review of the Literature
Open Access
- 9 October 2019
- journal article
- review article
- Published by MDPI AG in Journal of Mind and Medical Sciences
- Vol. 6 (2) , 210-215
Abstract
The second-generation of direct-acting antiviral agents are the current treatment for chronic viral hepatitis C infection. To evaluate the regression of liver fibrosis in patients receiving this therapy, liver biopsy remains the most accurate method, but the invasiveness of this procedure is its major drawback. Different non-invasive tests have been used to study changes in the stage of liver fibrosis in patients with chronic viral hepatitis treated with the second-generation of direct-acting antiviral agents: liver stiffness measurements (with transient elastography or acoustic radiation force impulse elastography) or different scores that use serum markers to calculate a fibrosis score. We prepared a literature review of the available data regarding the long-term evolution of liver fibrosis after the treatment with direct-acting antiviral agents for chronic viral hepatitis C.Keywords
This publication has 31 references indexed in Scilit:
- Performance of Acoustic Radiation Force Impulse Elastography for Staging Liver Fibrosis in Patients With Chronic Hepatitis C After Viral EradicationClinical Infectious Diseases, 2019
- Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antiviralsEuropean Journal of Clinical Investigation, 2018
- Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfectionAIDS, 2018
- Liver stiffness reduction and serum fibrosis score improvement in HIV/hepatitis C virus‐coinfected patients treated with direct‐acting antiviralsHIV Medicine, 2018
- Effect of Direct-Acting Agents on Fibrosis Regression in Chronic Hepatitis C Virus Patients' Treatment Compared with Interferon-Containing RegimensJournal of Interferon & Cytokine Research, 2018
- Serial changes in liver stiffness and controlled attenuation parameter following direct‐acting antiviral therapy against hepatitis C virus genotype 1bJournal of Medical Virology, 2017
- APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: Systematic review and meta-analysisArab Journal of Gastroenterology, 2017
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosisJournal of Hepatology, 2015
- Serum hyaluronic acid in chronic viral hepatitis B and C: a biomarker for assessing liver fibrosis in chronic hemodialysis patientsInternational Urology and Nephrology, 2015
- Ultrasound-Based Transient Elastography for the Detection of Hepatic Fibrosis: Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2007